Summary &mdash; The effect of cimaterol (2 mg/kg dry matter in the diet) and 15 
INTRODUCTION
The effects of oestrogenic or androgenic steroidal compounds in promoting growth and altering body composition in farm and laboratory animals has been well demonstrated (Galbraith and Topps, 1981 More recently there has been increasing interest in the effects of (3-adrenergic sympathomimetic compounds (&dquo;[3-agonists&dquo;) in a number of species (Reeds and Mersmann, 1991 ) .
Beta-agonists such as isoproterenol, salbutamol, racropamine, L-640-033 and BRL35135 are structural analogues of the catecholamines. A number of these synthetic compounds have shown considerable potential in the improvement of the growth performance and carcass characteristics of farm animals (Muir, 1988) . Two such compounds, clenbuterol (5-[1-hydroxy-2(isopropyl-amino)ethyl]anthranilonitrile) and cimaterol (4-amino-[t-butyl amino methyl]-3,5-dichlorobenzyl alcohol) are orally active and have been shown to increase skeletal muscle accretion and reduce fat deposition in a number of species (Reeds and Mersmann, 1991 ) .
The degree of similarity of the effects of anabolic steroids and those of [3-agonists in (Reeds and Mersmann, 1991 ). Oestradiol17p (OE) may act by altering responsiveness to somatotrophin (Buttery and Dawson, 1987 (Galbraith et al, 1990) . Briefly, both cimaterol and OE increased growth rate and protein deposited in the carcass, but cimaterol alone significantly reduced carcass fat accretion.
MATERIALS AND METHODS
A detailed description of animal selection, nutrition and experimental treatments has been given elsewhere (Galbraith et al, 1990 Rao and Hawkins (1976) , and assayed using the incubation conditions described by Krauss et al (1973) and the fatty acids extracted by the procedure of Schotz et al (1970) .
For practical reasons, comparison of lipogenic and lipolytic activity was made on the basis of wet weight of tissue rather than on an equivalence of cell numbers. Hu et al (1988) Pothoven and Beitz (1973) and Pothoven et al (1975) (Miller et al, 1986) and in rat epididymal fat pad incubated with an unspecified concentration of clenbuterol (Duquette and Muir, 1985) . Thornton et al (1985) reported markedly reduced rates of lipogenesis, stearate uptake and incorporation in subcutaneous ovine adipocytes incubated with 0.1 pg clenbuterol. A similar though nonsignificant trend apparent for overall rates of lipogenesis was seen in SCAT (table I) . In contrast, Hu et al (1988) (Pittman and Molinoff, 1983) , a decrease in the number of p-adrenergic receptors following chronic exposure to clenbuterol has been noted in rat skeletal muscle by Rothwell et al (1987) and Kim and Sainz (1990) Reeds et al (1987) .
The decrease in lipoprotein lipase activity in OE-treated animals is consistent with that reported in oestrogen-treated rat adipose tissue (Hamosh and Hamosh, 1975) . Although cimaterol has been reported to increase lipoprotein lipase activity in rat skeletal muscle (Eadara et al, 1987) , there was no evidence of any similar effect of cimaterol in adipose tissue.
Cimaterol has been previously been shown to cause a decrease in plasma urea concentration (Beermann et al, 1986 ; Galbraith et al, 1988) . Similarly, MacVinish and Galbraith (1988) (Basset, 1970; Beermann et al, 1985; Leenanuruska and 
